NRC: News Release - 2004-104 - Advisory Committee on the Medical Uses of Isotopes to Meet October 13

				Search Options
Index \| Site Map \| FAQ \| Facility Info \| Reading Rm \| New \| Help \| Glossary \| Contact Us

NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION
Office of Public Affairs	Telephone: 301/415-8200
Washington, DC 20555-0001	E-mail: opa@nrc.gov
www.nrc.gov

No. 04-104

September 1, 2004

ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES TO MEET
OCTOBER 13 - 14 IN ROCKVILLE, MARYLAND
Printable Version

The Advisory Committee on the Medical Uses of Isotopes (ACMUI) will meet at the Nuclear Regulatory Commission’s headquarters in Rockville, Md., on Oct. 13-14.

The meeting’s public session will run from 10 a.m. to 5 p.m. Oct. 13 and from 8 a.m. to 5 p.m. Oct. 14.

Agenda items for discussion in the public sessions include the use of Iodine-125 brachytherapy seeds as markers; proposed changes to abnormal occurrence criteria; discussion of medical event criteria; and an update on the St. Joseph’s Mercy Hospital dose reconstruction case. A complete agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/schedules/2004/.

Questions from the public will be permitted during the open sessions, at the discretion of the committee chairman. Persons who wish to provide a written statement should submit a reproducible copy to Angela R. McIntosh, Office of Nuclear Materials Safety and Safeguards, U.S. Nuclear Regulatory Commission, Mail Stop T-8F5, Washington, DC 20555-0001. Statements may also be e-mailed to Ms. McIntosh at arm@nrc.gov. Submissions should be postmarked by Sept. 15 and must pertain to the topics on the meeting agenda. For further information, contact Ms. McIntosh at (301) 415-5030.

Transcripts of the meeting and written comments will be available about Jan. 14, 2005, on the NRC’s web site, http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/, and in the NRC Public Document Room, 11555 Rockville Pike, telephone (800) 397-4209 or (301) 415-4737.